Julia Meade, MD

  • Assistant Professor of Pediatrics
  • Director, Pediatric Cancer Predisposition Program

Administrative Assistant: Amanda Hall

Julia Meade, MD, is a pediatric neuro-oncologist and certified in pediatric hematology/oncology by the American Board of Pediatrics. She is an assistant professor of pediatrics at the University of Pittsburgh School of Medicine in both the divisions of Pediatric Hematology/Oncology and Genetic and Genomic Medicine. She received her medical degree from Texas A&M University School of Medicine and completed her pediatric residency at the University of Colorado, followed by her heme/onc fellowship at UT Southwestern Medical Center and her pediatric neuro-oncology fellowship at Northwestern University.  Dr. Meade also holds a certificate in cancer risk assessment from the City of Hope.  

Dr. Meade is dedicated to the care of children with brain and spine tumors with additional expertise in the care of patients with neurofibromatosis, plexiform neurofibromas, and rare tumors.  Dr. Meade is the principal investigator for clinical trials investigating MEK-inhibitors for children with plexiform neurofibromas.  She is active in the development of national clinical trials through the Children’s Oncology Group.  Additionally, Dr. Meade is the director of the pediatric cancer predisposition program at the UPMC Children’s Hospital of Pittsburgh, which provides diagnosis, screening, and coordination of care for children with a genetically increased risk for cancer.  She is active in research and education surrounding cancer predisposition syndromes, including the mentorship of multiple genetic counseling students, graduate students, and medical trainees.  Dr. Meade’s is a member of the American Society of Pediatric Hematology/Oncology, the Children’s Oncology Group, the Adult Tumor Genes in Children and Adolescents Consortium, and the Pediatric Brain Tumor Consortium.  Dr. Meade lives in a dual-physician household and has three children. 

Education & Training

  • BA, Wellesley College, 2005
  • MD, Texas A&M University Health and Science Center College of Medicine, 2011
  • Residency, University of Colorado, 2014
  • Fellowship, UT Southwestern Medical Center, 2017
  • Fellowship, Northwestern University/Lurie Children's Hospital, 2018

Selected Publications

Venier, R; Maurer, L; Kessler, E; Ranganathan, S.; McGough, R.; Weiss, K.; Malek, M.; Meade, J.; Tersak, J.; Bailey, K. 2019. A germline BARD1 mutation in a patient with Ewing Sarcoma: implications for familial testing and counseling. Jun 3. Pediatr Blood Cancer. PMID: 31157509

Algattas, H; Abou-Al-Shaar, H; Mendelson, M; Arnold, G; Felker, J; Meade, J; Greene, S. 2020. Familial Cerebral Cavernous Malformation Syndrome with concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence? Cancer Genetics, in revision

Bey, E; Meade, J; Silvers, M; Motea, E; Patidar, P; Brekken, R; Deja, S; Merritt, M; Kilgore, J; Liu, Y; Huang, X; Li, L; Yordy, J; Williams, N; Gao, J; Boothman, D. “NQO1 Bioactivatable Drugs Modify Radiation Responses.” (2016) M.S. Anscher, K. Valerie (Eds.), Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Springer International Publishing, Switzerland.


View ORCID Record ORCID » 

Academic and Research Interests

  • Pediatric Cancer Predisposition Syndromes
  • Pediatric Cancer Genetics
  • Rare Pediatric Cancers 
  • Neurofibromatosis
  • Pediatric Brain Tumors